US$ 22.78
cjc w ipamorelin CJC‑1295 & Therapy Vitality Surge (CJC-1295 + Ipamorelin)
Description
References [1] Raun K, Hansen BS, Johansen NL, Thgersen H, Madsen K, Ankersen M, Andersen PH

The National Health Act provides that an eligible person receiving applicable treatment is entitled to receive pharmaceutical benefits without paying money or any other consideration, [xv] except as follows: A patient co-payment which, from 1 January 2024, is AU$31.60 (from 1 January 2026 it will be AU$25), or AU$7.70 if the patient has a concession card, for most PBS medicines

H.De AlwisD

Like CJC-1295 DAC, No DAC compounds are designed to activate the GHRH receptor
